OSR Holdings Inc
OSRH
NASDAQ
Biotechnology
$0.32
USD
+0.03 (+11.66%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $9.94M
Volume 2.7M
Revenue
$2.63M
TTM
— YoY
Gross Margin
22%
TTM
— YoY
Net Income
$-19.13M
TTM
— YoY
Operating Cash Flow
$-5.27M
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.8 | 1.1 | 0.6 | 0.4 | 0.5 |
YoY Growth | — | — | — | — | -36.4% |
Cost of Revenue | 0.6 | 1.1 | 0.4 | 0.3 | 0.3 |
Gross Profit | 0.2 | 0.0 | 0.3 | 0.1 | 0.2 |
Selling, General & Administrative | 3.1 | 5.3 | 4.1 | 6.5 | 3.8 |
Other Operating Expenses | 0.0 | -0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 3.1 | 5.3 | 4.1 | 6.5 | 3.8 |
Operating Income | -2.9 | -5.2 | -3.8 | -6.4 | -3.7 |
EBITDA | -0.6 | -2.9 | -1.4 | -4.1 | -1.2 |
Other Income / Expense | -8.5 | 0.0 | -0.7 | -1.0 | -0.2 |
Total Other Income / Expense | -8.5 | 0.0 | -0.7 | -1.4 | -0.3 |
Income Before Income Taxes | -11.4 | -5.2 | -4.5 | -7.8 | -3.9 |
Income Taxes | 0.0 | 0.0 | -1.3 | -0.5 | -0.5 |
Net Income | -11.4 | -5.2 | -3.2 | -7.2 | -3.5 |
Consolidated Net Income / Loss | -11.4 | -5.2 | -3.2 | -7.2 | -3.5 |
Net Income Attributable to Common Shareholders | -11.4 | 0.3 | -2.1 | -4.8 | -2.9 |
Basic EPS | -$1.04 | $0.02 | -$0.10 | -$0.16 | -$0.09 |
Diluted EPS | -$1.04 | $0.02 | -$0.10 | -$0.11 | -$0.09 |
Basic Shares Outstanding | 10.9M | 15.2M | 21.3M | 30.7M | 31.2M |
Diluted Shares Outstanding | 10.9M | 16.1M | 21.3M | 42.0M | 34.3M |